2026-01-26 - Analysis Report
**1. Company Overview**

UnitedHealth Group is a diversified health care company providing a range of products and services.

**2. Cumulative Return Analysis**

| Stock        | Cumulative Return |
|--------------|-------------------|
| UNH          | 41.32%            |
| VOO (S&P 500) | 126.41%           |
| Divergence  | -84.40            |

The cumulative return of UNH is lower than VOO by -84.40 percentage points.

**3. Alpha, Beta Analysis**

| Period | CAGR | MDD  | Alpha | Beta | Cap(B) |
|--------|------|------|-------|------|--------|
| 2016-2018 | 47.0% | 18.6% | 34.0% | 0.9 | 225.7B |
| 2017-2019 | 40.0% | 19.3% | 15.0% | 0.9 | 266.3B |
| 2018-2020 | 26.0% | 34.8% | 2.0% | 1.1 | 317.7B |
| 2019-2021 | 82.0% | 34.8% | 16.0% | 1.1 | 454.9B |
| 2020-2022 | 82.0% | 34.8% | 75.0% | 0.9 | 480.3B |
| 2021-2023 | 46.0% | 15.8% | 25.0% | 0.5 | 476.9B |
| 2022-2024 | -23.0% | 21.6% | -52.0% | 0.4 | 458.2B |
| 2023-2025 | -89.0% | 59.3% | -164.0% | 0.3 | 299.0B |

**4. Recent Stock Price Fluctuation**

| Metric | Value |
|--------|-------|
| Close  | $356.26 |
| 5-day SMA | $345.59 |
| 20-day SMA | $339.34 |
| 60-day SMA | $332.91 |

**5. RSI, PPO Index Indicators**

| Indicator | Value        |
|-----------|--------------|
| MRI (Market Risk Indicator) | 0.70        |
| RSI (Relative Strength Index) | 63.05       |
| PPO (Percentage Price Oscillator) | 0.47        |

**6. Recent News & Significant Events**

* Don't Buy UnitedHealth Group Stock Before Jan. 27 - The Motley Fool
* Morgan Stanley Issues Pessimistic Forecast for UnitedHealth Group (NYSE:UNH) Stock Price - MarketBeat
* UnitedHealth Stock Climbs 7.3% as Reddit Rage Fades to Neutral - Yahoo Finance
* U.S. politician makes super suspicious $500k healthcare stock trade - Finbold
* Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings? - TipRanks
* Buying UnitedHealth Before Q4 Earnings? Cost Pressures a Red Flag - Zacks Investment Research

**7. Analyst Opinions**

* Analyst Consensus: Buy
* Mean Opinion: 1.93 (~Buy)
* Opinions: 26
* Target Price (avg/high/low): $393.77, $444.00, $280.00

**8. Recent Earnings Analysis**

| Date    | EPS | Revenue (B$) |
|---------|-----|---------------|
| 2025-10-28 | 2.59 | 113.16        |
| 2025-08-11 | 3.76 | 111.62        |
| 2025-05-07 | 6.9  | 109.58        |
| 2024-11-04 | 6.56 | 100.82        |

**9. Financial Information**

**Revenue and Profitability**

| Quarter  | Revenue (B$) | Profit Margin (%) |
|----------|---------------|-------------------|
| 2025-09-30 | $113.16       | 18.24%            |
| 2025-06-30 | $111.62       | 17.93%            |
| 2025-03-31 | $109.58       | 21.70%            |
| 2024-12-31 | $100.81       | 21.14%            |
| 2024-09-30 | $100.82       | 22.84%            |

**Capital and Profitability**

| Quarter  | Equity (B$) | ROE (%)  |
|----------|--------------|----------|
| 2025-09-30 | $95.79       | 2.45%    |
| 2025-06-30 | $94.72       | 3.60%    |
| 2025-03-31 | $95.04       | 6.62%    |
| 2024-12-31 | $92.66       | 5.98%    |
| 2024-09-30 | $94.53       | 6.41%    |

**10. Comprehensive Analysis (Summary of previous items)**

UNH has a cumulative return of 41.32% lower than the S&P 500. The company's CAGR range from 26% to 82% with varying Betas, and the Alpha values range from 2% to 75%. The stock price has fluctuated, with the 5-day SMA at $345.59, 20-day SMA at $339.34, and 60-day SMA at $332.91. The RSI and PPO values indicate a medium risk level. Recent news suggests mixed opinions on the stock price. Analysts have a consensus buy rating with a target price range of $280-$444.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.